Skip to main content
SpringerLink
Log in

Ablation of Atrial Fibrillation and Atrial Tachycardia

  • Chapter
  • First Online:
Decoding Cardiac Electrophysiology

  • 799 Accesses

Abstract

Ablation for atrial fibrillation has now become the most common procedure performed in the electrophysiology laboratory. This chapter begins by exploring the clinical significance and pathogenesis of Atrial Fibrillation and reviews its ablative approaches and potential complications. One of the most common reasons for redo-ablation is for post AF Atrial Tachycardia, and this chapter will review their mechanisms, and some of the latest approaches to their 3D mapping.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AF:

Atrial Fibrillation

ANS:

Autonomic Nervous System

AT:

Atrial Tachycardia

CFAE:

Complex Fractionated Atrial Electrograms

CT:

Computed Tomography

ECG:

Electrocardiogram

EF:

Ejection Fraction

EGM:

Electrogram

GP:

Ganglionated Plexi

HFS:

High Frequency Stimulation

HR:

Heart Rate

LA:

Left Atrium

LAA:

Left Atrial Appendage

LAT:

Local Activation Time

LV:

Left Ventricle

MRI:

Magnetic Resonance Imaging

PV:

Pulmonary Vein

PVI:

Pulmonary Vein Isolation

RA:

Right atrium

RF:

Radiofrequency

SVC:

Superior Vena Cava

TOE:

Transoesophageal echocardiogram

WACA:

Wide area circumferential ablation

WOI:

Window of Interest

References

  1. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the american college of cardiology/american heart association task force on clinical practice guidelines and the heart rhythm society. Heart Rhythm. 2019.

    Google Scholar 

  2. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609–78.

    Article  PubMed  Google Scholar 

  3. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129(8):837–47.

    Article  PubMed  Google Scholar 

  4. Andersson T, Magnuson A, Bryngelsson IL, et al. All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case-control study. Eur Heart J. 2013;34(14):1061–7.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Wijesurendra RS, Liu A, Eichhorn C, et al. Lone atrial fibrillation is associated with impaired left ventricular energetics that persists despite successful catheter ablation. Circulation. 2016;134(15):1068–81.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Nerheim P, Birger-Botkin S, Piracha L, Olshansky B. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation. 2004;110(3):247–52.

    Article  PubMed  Google Scholar 

  7. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22(8):983–8.

    Article  CAS  PubMed  Google Scholar 

  8. Aspberg S, Chang Y, Atterman A, Bottai M, Go AS, Singer DE. Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation. Eur Heart J. 2016;37(42):3203–10.

    Article  PubMed  Google Scholar 

  9. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation. 2004;109(12):1509–13.

    Article  PubMed  Google Scholar 

  10. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347(23):1825–33.

    Article  CAS  PubMed  Google Scholar 

  11. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347(23):1834–40.

    Article  PubMed  Google Scholar 

  12. Ogawa S, Yamashita T, Yamazaki T, et al. Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM study. Circ J. 2009;73(2):242–8.

    Article  PubMed  Google Scholar 

  13. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation—pharmacological Intervention in atrial fibrillation (PIAF): a randomised trial. Lancet. 2000;356(9244):1789–94.

    Article  CAS  PubMed  Google Scholar 

  14. Siontis KC, Ioannidis JPA, Katritsis GD, et al. Radiofrequency ablation versus antiarrhythmic drug therapy for atrial fibrillation: meta-analysis of quality of life, morbidity, and mortality. JACC Clin Electrophysiol. 2016;2(2):170–80.

    Article  PubMed  Google Scholar 

  15. Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417–27.

    Article  PubMed  Google Scholar 

  16. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–66.

    Article  CAS  PubMed  Google Scholar 

  17. Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation. 2000;102(21):2619–28.

    Article  CAS  PubMed  Google Scholar 

  18. Sundt TM 3rd, Camillo CJ, Cox JL. The maze procedure for cure of atrial fibrillation. Cardiol Clin. 1997;15(4):739–48.

    Article  PubMed  Google Scholar 

  19. Hamabe A, Okuyama Y, Miyauchi Y, et al. Correlation between anatomy and electrical activation in canine pulmonary veins. Circulation. 2003;107(11):1550–5.

    Article  PubMed  Google Scholar 

  20. Kumagai K, Ogawa M, Noguchi H, Yasuda T, Nakashima H, Saku K. Electrophysiologic properties of pulmonary veins assessed using a multielectrode basket catheter. J Am Coll Cardiol. 2004;43(12):2281–9.

    Article  PubMed  Google Scholar 

  21. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92(7):1954–68.

    Article  CAS  PubMed  Google Scholar 

  22. Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J. 1959;58(1):59–70.

    Article  CAS  PubMed  Google Scholar 

  23. Moe GK, Rheinboldt WC, Abildskov JA. A computer model of atrial fibrillation. Am Heart J. 1964;67:200–20.

    Article  CAS  PubMed  Google Scholar 

  24. Calkins H, Reynolds MR, Spector P, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2(4):349–61.

    Article  CAS  PubMed  Google Scholar 

  25. Nielsen JC, Johannessen A, Raatikainen P, et al. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial. Heart. 2017;103(5):368–76.

    Article  PubMed  Google Scholar 

  26. Morillo CA, Verma A, Connolly SJ, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014;311(7):692–700.

    Article  CAS  PubMed  Google Scholar 

  27. Mont L, Bisbal F, Hernandez-Madrid A, et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2014;35(8):501–7.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019.

    Google Scholar 

  29. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. J Arrhythm. 2017;33(5):369–409.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Jiang RH, Po SS, Tung R, et al. Incidence of pulmonary vein conduction recovery in patients without clinical recurrence after ablation of paroxysmal atrial fibrillation: mechanistic implications. Heart Rhythm. 2014;11(6):969–76.

    Article  PubMed  Google Scholar 

  31. Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32–8.

    Article  PubMed  Google Scholar 

  32. Andrade JG, Khairy P, Macle L, et al. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter sustained treatment of paroxysmal atrial fibrillation (STOP AF) trial. Circ Arrhythm Electrophysiol. 2014;7(1):69–75.

    Article  PubMed  Google Scholar 

  33. Kuck KH, Brugada J, Furnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374(23):2235–45.

    Article  PubMed  Google Scholar 

  34. Dallaglio PD, Betts TR, Ginks M, Bashir Y, Anguera I, Rajappan K. The role of adenosine in pulmonary vein isolation: a critical review. Cardiol Res Pract. 2016;2016:8632509.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Deneke T, Jais P, Scaglione M, et al. Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review. J Cardiovasc Electrophysiol. 2015;26(4):455–63.

    Article  PubMed  Google Scholar 

  36. Wazni OM, Beheiry S, Fahmy T, et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation. 2007;116(22):2531–4.

    Article  PubMed  Google Scholar 

  37. Deshmukh A, Patel NJ, Pant S, et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation. 2013;128(19):2104–12.

    Article  PubMed  Google Scholar 

  38. Ghia KK, Chugh A, Good E, et al. A nationwide survey on the prevalence of atrioesophageal fistula after left atrial radiofrequency catheter ablation. J Interv Card Electrophysiol. 2009;24(1):33–6.

    Article  PubMed  Google Scholar 

  39. Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812–22.

    Article  PubMed  Google Scholar 

  40. Chen SA, Tai CT. Catheter ablation of atrial fibrillation originating from the non-pulmonary vein foci. J Cardiovasc Electrophysiol. 2005;16(2):229–32.

    Article  PubMed  Google Scholar 

  41. Fassini G, Riva S, Chiodelli R, et al. Left mitral isthmus ablation associated with PV Isolation: long-term results of a prospective randomized study. J Cardiovasc Electrophysiol. 2005;16(11):1150–6.

    Article  PubMed  Google Scholar 

  42. Kottkamp H, Berg J, Bender R, Rieger A, Schreiber D. Box isolation of fibrotic areas (BIFA): a patient-tailored substrate modification approach for ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27(1):22–30.

    Article  PubMed  Google Scholar 

  43. Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004;43(11):2044–53.

    Article  PubMed  Google Scholar 

  44. Pokushalov E, Romanov A, Katritsis DG, et al. Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison. Heart Rhythm. 2013;10(9):1280–6.

    Article  PubMed  Google Scholar 

  45. Rappel WJ, Narayan SM. Theoretical considerations for mapping activation in human cardiac fibrillation. Chaos. 2013;23(2):023113.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Gianni C, Mohanty S, Di Biase L, et al. Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation. Heart Rhythm. 2016;13(4):830–5.

    Article  PubMed  Google Scholar 

  47. Jais P, Matsuo S, Knecht S, et al. A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: importance of localized reentry. J Cardiovasc Electrophysiol. 2009;20(5):480–91.

    Article  PubMed  Google Scholar 

  48. Zhang XD, Gu J, Jiang WF, et al. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial. Eur Heart J. 2014;35(20):1327–34.

    Article  PubMed  Google Scholar 

  49. Del Carpio Munoz F, Buescher TL, Asirvatham SJ. Three-dimensional mapping of cardiac arrhythmias: what do the colors really mean? Circ Arrhythm Electrophysiol. 2010;3(6):e6–11.

    Google Scholar 

  50. Liuba I, Walfridsson H. Activation mapping of focal atrial tachycardia: the impact of the method for estimating activation time. J Interv Card Electrophysiol. 2009;26(3):169–80.

    Article  PubMed  Google Scholar 

  51. De Ponti R, Verlato R, Bertaglia E, et al. Treatment of macro-re-entrant atrial tachycardia based on electroanatomic mapping: identification and ablation of the mid-diastolic isthmus. Europace. 2007;9(7):449–57.

    Article  PubMed  Google Scholar 

  52. Jamil-Copley S, Linton N, Koa-Wing M, et al. Application of ripple mapping with an electroanatomic mapping system for diagnosis of atrial tachycardias. J Cardiovasc Electrophysiol. 2013;24(12):1361–9.

    Article  PubMed  Google Scholar 

  53. Linton NW, Koa-Wing M, Francis DP, et al. Cardiac ripple mapping: a novel three-dimensional visualization method for use with electroanatomic mapping of cardiac arrhythmias. Heart Rhythm. 2009;6(12):1754–62.

    Article  PubMed  Google Scholar 

  54. Luther V, Linton NW, Koa-Wing M, et al. A prospective study of ripple mapping in atrial tachycardias: a novel approach to interpreting activation in low-voltage areas. Circ Arrhythm Electrophysiol. 2016;9(1):e003582.

    Article  PubMed  Google Scholar 

  55. Luther V, Cortez-Dias N, Carpinteiro L, et al. Ripple mapping: initial multicenter experience of an intuitive approach to overcoming the limitations of 3D activation mapping. J Cardiovasc Electrophysiol. 2017;28(11):1285–94.

    Article  PubMed  Google Scholar 

  56. Luther V, Qureshi N, Lim PB, et al. Isthmus sites identified by ripple mapping are usually anatomically stable: a novel method to guide atrial substrate ablation? J Cardiovasc Electrophysiol. 2018;29(3):404–11.

    Article  PubMed  Google Scholar 

  57. Luther V, Agarwal S, Chow A et al. Ripple-AT study. Circ Arrhythm Electrophysiol. 2019;12(8):e007394.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London, UK

    Vishal Luther

  2. National Heart and Lung Institute, Imperial College London, London, UK

    George Katritsis

Authors
  1. Vishal Luther
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Katritsis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vishal Luther .

Editor information

Editors and Affiliations

  1. St Bartholomew’s Hospital, London, UK

    Afzal Sohaib

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Luther, V., Katritsis, G. (2020). Ablation of Atrial Fibrillation and Atrial Tachycardia. In: Sohaib, A. (eds) Decoding Cardiac Electrophysiology. Springer, Cham. https://doi.org/10.1007/978-3-030-28672-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-28672-9_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-28671-2

  • Online ISBN: 978-3-030-28672-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation